Cancellation of state registration. Tamoxifen-Ebwee

November 17, 2016
Active substances:
Trade names:
ICD-10:
II.C43-C44    Melanoma and other malignant neoplasms of the skin
II.C50    Malignant neoplasm of breast)
II.C51-C58.C56    Malignant neoplasm of ovary
II.C60-C63.C61    Malignant neoplasm of prostate
II.C64-C68.C64    Malignant neoplasm of kidney, except for renal pelvis
Tamoxifen, melanoma, breast cancer, ovarian cancer, prostate cancer, kidney cancer

The Ministry of Health of the Russian Federation in accordance with Article 32 of the Federal Law of 12.04.2010 No. 61-FZ "On the circulation of medicinal products" decided to abolish state registration and exclude from the state register of medicinal products for medical use of the medicinal product (registration certificate P N015178 / 01 -2003 dated 16.06.2008, issued to Ebwe Pharma Gesm.b.X Nfg. KG, Austria):

Tamoxifen - Ebwee (trade name of the medicinal product)

Tamoxifen (international non-patented or batch or chemical name)

tablets, 10 mg, 20 mg, 30 mg, 40 mg (dosage form, dosage)

Ebewe Pharma Gesmb.b. Nfg. KG., Austria Mondseestrasse 11, A-4866, Unterach am Attersee, Austria (name and address of the location of the manufacturer of the medicinal product)

on the basis of the application of CJSC "Sandoz" application for a medicinal product.